Deschamps Charlotte, Fournier Elora, Uriot Ophélie, Lajoie Frédérique, Verdier Cécile, Comtet-Marre Sophie, Thomas Muriel, Kapel Nathalie, Cherbuy Claire, Alric Monique, Almeida Mathieu, Etienne-Mesmin Lucie, Blanquet-Diot Stéphanie
Université Clermont Auvergne, INRAe, UMR 454 MEDIS, 28 place Henri Dunant, F-63000, Clermont-Ferrand, France.
Département de Pharmacologie et Physiologie, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada.
Appl Microbiol Biotechnol. 2020 Dec;104(23):10233-10247. doi: 10.1007/s00253-020-10959-4. Epub 2020 Oct 21.
In vitro gut models, such as the mucosal artificial colon (M-ARCOL), provide timely and cost-efficient alternatives to in vivo assays allowing mechanistic studies to better understand the role of human microbiome in health and disease. Using such models inoculated with human fecal samples may require a critical step of stool storage. The effects of preservation methods on microbial structure and function in in vitro gut models have been poorly investigated. This study aimed to assess the impact of three commonly used preserving methods, compared with fresh fecal samples used as a control, on the kinetics of lumen and mucus-associated microbiota colonization in the M-ARCOL model. Feces from two healthy donors were frozen 48 h at - 80 °C with or without cryoprotectant (10% glycerol) or lyophilized with maltodextrin and trehalose prior to inoculation of four parallel bioreactors (e.g., fresh stool, raw stool stored at - 80 °C, stool stored at - 80 °C with glycerol and lyophilized stool). Microbiota composition and diversity (qPCR and 16S metabarcoding) as well as metabolic activity (gases and short chain fatty acids) were monitored throughout the fermentation process (9 days). All the preservative treatments allowed the maintaining inside the M-ARCOL of a complex and functional microbiota, but considering stabilization time of microbial profiles and activities (and not technical constraints associated with the supply of frozen material), our results highlighted 48 h freezing at - 80 °C without cryoprotectant as the most efficient method. These results will help scientists to determine the most accurate method for fecal storage prior to inoculation of in vitro gut microbiome models. KEY POINTS: • In vitro ARCOL model reproduces luminal and mucosal human microbiome. • Short-term storage of fecal sample influences microbial stabilization and activity. • 48 h freezing at - 80°C: most efficient method to preserve microbial ecosystem. • Scientific and technical requirements: influencers of preservation method.
体外肠道模型,如黏膜人工结肠(M-ARCOL),为体内试验提供了及时且经济高效的替代方案,使机理研究能够更好地理解人类微生物群在健康和疾病中的作用。使用接种了人类粪便样本的此类模型可能需要一个关键的粪便储存步骤。保存方法对体外肠道模型中微生物结构和功能的影响尚未得到充分研究。本研究旨在评估三种常用保存方法与用作对照的新鲜粪便样本相比,对M-ARCOL模型中肠腔和黏液相关微生物群定植动力学的影响。来自两名健康供体的粪便在接种四个平行生物反应器之前(例如,新鲜粪便、-80°C储存的未处理粪便、-80°C含甘油储存的粪便和冻干粪便),在-80°C下冷冻48小时(有无冷冻保护剂(10%甘油))或用麦芽糖糊精和海藻糖冻干。在整个发酵过程(9天)中监测微生物群组成和多样性(定量聚合酶链反应和16S宏条形码分析)以及代谢活性(气体和短链脂肪酸)。所有保存处理都能使复杂且有功能的微生物群在M-ARCOL中得以维持,但考虑到微生物特征和活性的稳定时间(而非与冷冻材料供应相关的技术限制),我们的结果突出显示,在-80°C下无冷冻保护剂冷冻48小时是最有效的方法。这些结果将有助于科学家确定在接种体外肠道微生物群模型之前粪便储存的最准确方法。要点:•体外ARCOL模型可重现人类肠腔和黏膜微生物群。•粪便样本的短期储存会影响微生物的稳定性和活性。•在-80°C下冷冻48小时:保存微生物生态系统的最有效方法。•科学和技术要求:保存方法的影响因素。
Appl Microbiol Biotechnol. 2020-12
J Microbiol Methods. 2021-6
Sheng Wu Gong Cheng Xue Bao. 2020-12-25
J Formos Med Assoc. 2020-12
NPJ Biofilms Microbiomes. 2024-9-8
Appl Microbiol Biotechnol. 2024-1-23
Front Cell Infect Microbiol. 2020
Nat Rev Gastroenterol Hepatol. 2020-2-19
Nucleic Acids Res. 2020-1-8
World J Mens Health. 2020-1
Front Physiol. 2018-11-12
Appl Microbiol Biotechnol. 2018-3-1